Verily Life Sciences Stories May 19, 2020

After much confusion over the last three days, Google sister company Verily has launched its coronavirus screener and testing website. It does not have the nationwide capability — currently only covering the Bay Area — originally alluded to by US officials.

expand full story

Verily Life Sciences Stories March 26, 2020

Last Sunday, Alphabet’s life sciences division launched a Baseline COVID-19 Pilot Program in California. It’s expanded to more sites since then, and Verily today released a video explaining what drive-thru COVID-19 testing participants can expect.

expand full story

Verily Life Sciences Stories March 15, 2020

Following the Friday announcement of a COVID-19 website from “Google” by US officials, there was immediate confusion about the scope and scale. Alphabet company Verily today detailed its upcoming coronavirus testing website.

expand full story

Verily Life Sciences Stories March 13, 2020

The United States this afternoon declared a national emergency to better respond to COVID-19. During that press conference, President Trump and officials announced that Google was building a screening website to help with increased coronavirus testing. It has since emerged that what’s actually being developed is much more limited in scope.

expand full story

Verily Life Sciences Stories January 23, 2020

Even before Google’s Fitbit acquisition, Alphabet already has a health wearable with the Verily Study Watch. That clinical device has just received FDA clearance to detect irregular heart rhythms.

expand full story

Verily Life Sciences Stories January 9, 2020

Next to Waymo, Verily is likely Alphabet’s most promising ‘bet’ given the burgeoning technology and healthcare field. The company today announced that it has hired ex-Tesla chief financial officer Deepak Ahuja to take on the same role.

expand full story

Verily Life Sciences Stories February 25, 2019

For the past three years, Google and Verily have leveraged machine learning to screen for the two leading causes of preventable blindness in adults. In India, this algorithm is now being used in a clinical setting, while the European Union has certified it as a medical device.

expand full story

Verily Life Sciences Stories February 6, 2019

For the past several years, the U.S. has experienced a public health emergency due to opioid overdoses. Verily today announced the OneFifteen nonprofit to combat the crisis by building a high-tech campus for rehabilitation that leverages data.

expand full story

Verily Life Sciences Stories February 1, 2019

Verily has a number of ongoing hardware and sensor projects from the recently FDA-approved ECG Study Watch to Smart Lenses for corrective vision. A new report today reveals that the Alphabet division is working on health-tracking shoes.

expand full story

Verily Life Sciences Stories January 18, 2019

FDA clears ECG feature on Verily Study Watch for medical research

Verily has a number of ongoing hardware projects from smart contact lenses to miniaturized continuous glucose monitors. Alphabet’s health division is also working on a Study Watch that was just granted ECG clearance by the FDA.

Verily Life Sciences Stories January 3, 2019

After Waymo, Verily is Alphabet’s next most promising ‘bet’ by focussing on how technology can revolutionize healthcare and medicine in the coming years. To fund “growth and innovation,” Verily today announced a $1 billion investment round.

expand full story

Verily Life Sciences Stories December 19, 2018

Technology has the potential to revolutionize healthcare over the coming years with Google internally spinning up a health division, while Alphabet has Verily. The latter today announced a strategic partnership with Walgreens on multiple projects to help patients with chronic conditions, and lower the cost of care.

expand full story

Verily Life Sciences Stories November 16, 2018

One of Verily’s first projects was to make contact lenses that could detect glucose levels from teardrops. Less invasive than fingertip blood pricks for people living with diabetes, the Alphabet company and partner Alcon today announced that it is putting that project “on hold” due to the diabetes premise not being suitable.

expand full story

Verily Life Sciences Stories August 14, 2018

In recent years, more and more startups have worked to disrupt traditional industries by leveraging technology and big data. Oscar was founded in 2012 to improve health insurance, and today it received a $375 million investment from Alphabet.

expand full story

Verily Life Sciences Stories May 11, 2018

Verily’s health ambitions include both data analysis and developing hardware sensors. In addition to current projects to make a continuous glucose monitor, the Alphabet health division is now rumored to be working on devices that can non-invasively collect blood.

expand full story

Verily Life Sciences Stories May 6, 2018

In 2015, President Obama announced the Precision Medicine Initiative to research individualized health care. Today, that All of Us program is officially launching and open for enrollment. With several components, Verily will be working on storing and organizing data for researchers.

expand full story

Verily Life Sciences Stories February 27, 2018

Verily might be entering the health insurance market according to a new report this morning. Alphabet’s health division would not become an insurer, but rather work with existing ones and other partners to lower patient costs.

expand full story

Verily Life Sciences Stories February 19, 2018

Alphabet’s health division, Verily, has a number of ongoing projects that leverage technology and data science to improve healthcare. The latest applies machine learning to retinal images to identify the risk factors of cardiovascular disease.

expand full story

Verily Life Sciences Stories September 6, 2017

Back in July, a report revealed that Verily Life Sciences made an investment and built a lab for cancer detection startup Freenome at its campus. The Alphabet division has now revealed that the lab and offices are a part of the Verily Partner Space to foster collaboration with “pioneering start-ups.”

expand full story

Verily Life Sciences Stories July 24, 2017

According to a new report from CNBC, Alphabet’s Life Sciences arm Verily has invested in a cancer detection startup called Freenome. It’s unclear just how much Verily put into the company, but its latest round totaled around $65 million.

expand full story

Verily Life Sciences Stories July 14, 2017

Verily Life Sciences is set to release 20 million modified mosquitos in Fresno, California throughout the summer. Aimed at reducing the global impact of the disease-carrying insect, this is the Alphabet company’s first U.S. field study.

expand full story

Verily Life Sciences Stories May 9, 2017

As part of its broader research into life sciences, Verily is tackling mental health by using technology to allow for earlier diagnosis and intervention. However, the Alphabet division has lost a major hire, with Dr. Thomas Insel departing.

expand full story

Verily Life Sciences Stories April 19, 2017

Following last week’s announcement of the Study Watch, Verily is starting its four-year study to quantify good health with biometric data. In better understanding health, Baseline hopes to ultimately prevent diseases, as the Alphabet division continues work on other health gadgets.

expand full story

Verily Life Sciences Stories April 14, 2017

For the past two years, Verily — previously known as Google Life Sciences — has been working on a wearable that records vast amounts of health data. The Alphabet company is now showing off the rather sleek Verily Study Watch for the first time.

expand full story

Verily Life Sciences Stories September 28, 2016

verily-alphabet

While Google is rumored to be prepping up to two new in-house made Android Wear smartwatches — which may or may not be featured in next week’s event — a spinoff of Alphabet‘s former Google X named Verily is still actively working on its health-tracking watch (via MIT Technology Review), which is slowly advancing towards being a finished product…

expand full story

Verily Life Sciences Stories August 1, 2016

chip_close_a4_

It doesn’t seem that long ago when putting tiny machines into people’s bodies to cure or manage diseases was the stuff of science-fiction, but bioelectronics is a real – if very new – field of medicine. Alphabet’s Verily Life Sciences (formerly Google Life Sciences) and pharma company GSK are teaming up to invest $715M in the tech over the next seven years.

Bioelectronic medicine is a relatively new scientific field that aims to tackle a wide range of chronic diseases using miniaturised, implantable devices that can modify electrical signals that pass along nerves in the body, including irregular or altered impulses that occur in many illnesses. GSK has been active in this field since 2012 and believes certain chronic conditions such as arthritis, diabetes and asthma could potentially be treated using these devices … 

expand full story

Verily Life Sciences Stories July 1, 2016

google-alphabet

The goal of last year’s Alphabet re-org was to effectively turn Google’s many research divisions into startups that make profitable products and services. To better incentivize executives and employees, a new report (via Bloomberg) says that Alphabet is implementing a new type of stock compensation whose value is tied to the performance of each company.

expand full story

Verily Life Sciences Stories April 13, 2016

screen-shot-2015-12-07-at-6-15-46-pm

There has been quite a bit of press surrounding the behind-the-scenes aspect of Alphabet companies over recent weeks, mainly centered around Nest and Tony Fadell. Earlier today, it was reported that Fadell appeared at Google’s all-hands meeting two-weeks ago to address the stream of negative press. In addition to Fadell defending Nest, Re/code now reports that executive Sergey Brin also defended the company’s life science unit, Verily, at the meeting.

expand full story

Verily Life Sciences Stories March 9, 2016

Screen Shot 2016-03-09 at 10.21.54 PM According to a recent FCC filling, Alphabet’s Life Sciences wing Verily has recently developed a new “Connectivity Bridge” for use in clinical studies. The device is capable of collecting and syncing medical information of people participating in clinical studies, allowing Google to continue to improve its efforts in healthcare.

expand full story

Verily Life Sciences Stories December 7, 2015

Screen Shot 2015-12-07 at 6.15.46 PM

Now that the Alphabet restructuring is kicking into gear, the company today has renamed its experimental health care branch. The branch was originally named Google Life Sciences, but from here on out will be known as “Verily.” The goals of Verily are identical to Life Sciences and the only thing that’s really changing is the name.

expand full story

Powered by WordPress VIP